{"schema_version":"1","generated_at":"2026-10-28T07:18:48.578Z","data_as_of":"2026-10-17","url":"https://www.findmykol.com/kol/scot-remick","json_url":"https://www.findmykol.com/kol/scot-remick/profile.json","record_kind":"full","profile_kind":"clinical","person":{"slug":"scot-remick","name":"Scot Remick","credential":"MD","title":"Chief of Oncology, MaineHealth Maine Medical Center","specialty":"Medical Oncology","specialty_raw":"Medical Oncology","therapeutic_area":"Lymphoma","therapeutic_areas":["Lymphoma","Leukemia"],"institution":"MaineHealth Maine Medical Center","institution_url":"https://www.findmykol.com/institution/mainehealth-maine-medical-center","city":"Scarborough","state":"ME","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"},"country":{"name":"United States","code":"US","status":"verified"}},"identifiers":{"npi":"1417977067","orcid":"0000-0003-0215-310X","openalex":"A5060442605"},"summary":"Scot Remick is Chief of Oncology, MaineHealth Maine Medical Center at MaineHealth Maine Medical Center. OpenAlex indexes 223 publications with 8,639 citations (h-index 47); ClinicalTrials.gov lists 20 registered studies with this person as an investigator.","overview":{"text":"Scot C. Remick, MD, is Chief of Oncology, MaineHealth Maine Medical Center. The public record shows 223 publications with 8,639 citations (h-index 47), centered on Viral-associated cancers and disorders, Lymphoma Diagnosis and Treatment, Cancer Treatment and Pharmacology. It also documents an investigator role on 20 registered clinical trials, industry payments reported by 2 companies, 2 NIH-funded awards (2015–2026).","bullets":["Most recent indexed publication: 2026 · Journal of Maine Medical Center","Top research focus: Viral-associated cancers and disorders","20 registered trials on ClinicalTrials.gov","Open Payments reporting from 2 companies"],"generated_at":"2026-10-27"},"focus":{"indications":[{"label":"Lymphoma","therapeutic_area":"Oncology","trials":9,"topics":1,"strength":28},{"label":"Breast Cancer","therapeutic_area":"Oncology","trials":3,"topics":0,"strength":9},{"label":"Head & Neck Cancer","therapeutic_area":"Oncology","trials":2,"topics":0,"strength":6},{"label":"Acquired Immunodeficiency Syndrome","therapeutic_area":"Infectious Disease","trials":2,"topics":0,"strength":6},{"label":"Melanoma","therapeutic_area":"Oncology","trials":2,"topics":0,"strength":6},{"label":"Hodgkin Disease","therapeutic_area":"Oncology","trials":2,"topics":0,"strength":6},{"label":"Sarcoma","therapeutic_area":"Oncology","trials":2,"topics":0,"strength":6},{"label":"Coma","therapeutic_area":"Neurology","trials":2,"topics":0,"strength":6},{"label":"Kidney Cancer / RCC","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Kidney Neoplasms","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"ST Elevation Myocardial Infarction","therapeutic_area":"Cardiology","trials":1,"topics":0,"strength":3},{"label":"Colorectal Cancer","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Lymphoma, Non-Hodgkin","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Carcinoma, Small Cell","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Skin Neoplasms","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Sarcoma, Kaposi","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"AIDS-related Kaposi sarcoma","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Leukemia (AML/ALL/CML/CLL)","therapeutic_area":"Oncology","trials":0,"topics":1,"strength":1}],"research_topics":["Viral-associated cancers and disorders","Lymphoma Diagnosis and Treatment","Cancer Treatment and Pharmacology","Chronic Lymphocytic Leukemia Research","Angiogenesis and VEGF in Cancer"],"works_with":{"total":7,"shown":3,"withheld":4,"rows":[{"name":"Case Comprehensive Cancer Center","trials":14,"payments":0,"mentions":14},{"name":"Janssen Research & Development, LLC","trials":0,"payments":4,"mentions":4},{"name":"National Cancer Institute (NCI)","trials":2,"payments":0,"mentions":2}]}},"scholarship":{"works_count":223,"cited_by_count":8639,"h_index":47,"i10_index":124,"pubmed_count":2,"latest_activity_year":2026,"source":"works"},"trials":{"count":20,"shown":3,"withheld":17,"matched_by":"identity-adjudicated record","rows":[{"nct":"NCT07089225","title":"A Study in Patients Reporting Cannabis Use Followed With an Application-Based Cannabis Journal","status":"NOT_YET_RECRUITING","role":"Investigator","sponsor":"Scot Remick","source_url":"https://clinicaltrials.gov/study/NCT07089225","trial_url":"https://www.findmykol.com/trial/NCT07089225"},{"nct":"NCT06904391","title":"Education & Mentorship of Advanced Practice Providers to Increase Community-based Research Within the NCORP Network, COACH-APP Trial","phase":"NA","status":"RECRUITING","role":"Investigator","sponsor":"Wake Forest University Health Sciences","source_url":"https://clinicaltrials.gov/study/NCT06904391","trial_url":"https://www.findmykol.com/trial/NCT06904391"},{"nct":"NCT06418204","title":"Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics","status":"RECRUITING","role":"Investigator","sponsor":"Wake Forest University Health Sciences","source_url":"https://clinicaltrials.gov/study/NCT06418204","trial_url":"https://www.findmykol.com/trial/NCT06418204"}],"source":"trials"},"payments":{"company_count":2,"program_years":{"first":2021,"last":2024},"rows_total":3,"shown":3,"withheld":0,"rows":[{"payer":"Tempus AI, Inc","program_year":2024,"amount_usd":69.03,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1417977067"},{"payer":"Janssen Research & Development, LLC","program_year":2022,"amount_usd":1000,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1417977067"},{"payer":"Janssen Research & Development, LLC","program_year":2021,"amount_usd":3000,"payment_count":3,"source_url":"https://openpaymentsdata.cms.gov/search?query=1417977067"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1417977067","source":"payments"},"funding":{"award_count":2,"fiscal_years":{"first":2015,"last":2026},"rows_total":104,"shown":3,"withheld":101,"rows":[{"project":"UG1CA239771","title":"MaineHealth Cancer Care Network (MHCCN) and NCORP Activities across the Lifespan","fiscal_year":2026,"amount_usd":978001,"organization":"MAINEHEALTH","source_url":"https://reporter.nih.gov/quickSearch/UG1CA239771"},{"project":"UG1CA239771","title":"MaineHealth Cancer Care Network (MHCCN) and NCORP Activities across the Lifespan","fiscal_year":2025,"amount_usd":1076001,"organization":"MAINEHEALTH","source_url":"https://reporter.nih.gov/quickSearch/UG1CA239771"},{"project":"UG1CA239771","title":"MaineHealth Cancer Care Network (MHCCN) and NCORP Activities across the Lifespan","fiscal_year":2024,"amount_usd":1076001,"organization":"MAINEHEALTH","source_url":"https://reporter.nih.gov/quickSearch/UG1CA239771"}],"source":"grants"},"congress":{"count":29,"years":{"first":2004,"last":2026},"societies":["ASCO","ASTRO"],"shown":3,"withheld":26,"rows":[{"title":"A retrospective analysis of outcomes in metastatic solid tumors harboring alterations in the PI3K pathway as stratified by the presence or absence of diseases of insulin resistance.","society":"ASCO","meeting":"ASCO Annual Meeting","year":2026,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1200/jco.2026.44.16_suppl.e22668","source_url":"https://doi.org/10.1200/jco.2026.44.16_suppl.e22668","status":"verified"},{"title":"Real-world utilization of upfront genomic testing in newly diagnosed non–small cell lung cancer in a rural state.","society":"ASCO","meeting":"ASCO Annual Meeting","year":2026,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1200/jco.2026.44.16_suppl.e23377","source_url":"https://doi.org/10.1200/jco.2026.44.16_suppl.e23377","status":"verified"},{"title":"Comparative risk of obesity-related cancer with glucagon-like protein-1 receptor agonists vs. bariatric surgery in patients with BMI ≥ 35.","society":"ASCO","meeting":"ASCO Annual Meeting","year":2024,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1200/jco.2024.42.16_suppl.10508","source_url":"https://doi.org/10.1200/jco.2024.42.16_suppl.10508","status":"verified"}],"source":"congress"},"publications":{"total":2,"shown":2,"withheld":0,"matched_by":"ORCID record, linked to PubMed","recent":[{"title":"Survey of MaineHealth Cancer Care Network Providers on Cannabis Use: Preparation for Studies Sponsored by the National Cancer Institute.","year":2026,"journal":"Journal of Maine Medical Center","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/41640792/","status":"verified"},{"title":"Seeking American Society of Clinical Oncology-Quality Oncology Practice Initiative (ASCO-QOPI) certification in a northern New England rural health system and cancer care network.","year":2024,"journal":"Learning health systems","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/39036533/","status":"verified"}],"most_cited":{"total":223,"shown":5,"withheld":218,"rows":[{"title":"Rates of Initial and Recurrent Thromboembolic Disease Among Patients with Malignancy Versus Those without Malignancy: Risk Analysis Using Medicare Claims Data","year":1999,"cited_by_count":893,"source_url":"https://doi.org/10.1097/00005792-199909000-00001"},{"title":"Initial Assessment, Surveillance, and Management of Blood Pressure in Patients Receiving Vascular Endothelial Growth Factor Signaling Pathway Inhibitors","year":2010,"cited_by_count":409,"source_url":"https://doi.org/10.1093/jnci/djq091"},{"title":"A phase I pharmacokinetic and translational study of the novel vascular targeting agent combretastatin a-4 phosphate on a single-dose intravenous schedule in patients with advanced cancer.","year":2002,"cited_by_count":406,"source_url":"https://openalex.org/A5060442605"},{"title":"Anaplastic Thyroid Cancer: A Review of Epidemiology, Pathogenesis, and Treatment","year":2011,"cited_by_count":321,"source_url":"https://doi.org/10.1155/2011/542358"},{"title":"Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma","year":2009,"cited_by_count":256,"source_url":"https://doi.org/10.1182/blood-2009-08-231613"}]},"source":"publications"},"network":{"coauthors_total":40,"shown":3,"withheld":37,"coauthors":[{"name":"Afshin Dowlati","coauthored_works":41,"profile_url":"https://www.findmykol.com/kol/afshin-dowlati"},{"name":"Matthew M. Cooney","coauthored_works":21},{"name":"William Tse","coauthored_works":20,"profile_url":"https://www.findmykol.com/kol/william-tse"}],"source":"works"},"presence":{"owned_accounts":{"total":1,"shown":1,"rows":[{"platform":"doximity","url":"https://www.doximity.com/pub/scot-remick-md","status":"verified"}]},"mentions":{"total":3,"shown":3,"rows":[{"url":"https://www.facebook.com/MaineMedicalCenter/posts/our-chief-of-oncology-dr-scot-remick-appeared-on-wcsh-6-and-wlbz-2-last-night-to/10155407192479383/","platform":"facebook","status":"verified"},{"url":"https://www.instagram.com/p/DNQ18nctYP8/","platform":"instagram","status":"verified"},{"url":"https://www.linkedin.com/posts/mainehealth-institute-for-research_scot-c-remick-md-activity-7279552702957727745-sD6T","platform":"linkedin","status":"verified"}]},"verified_means":"confirmed in more than one place; provisional means found and still being confirmed"},"recognition":{"education":{"total":4,"shown":4,"rows":[{"value":"Board Certified, Medical Oncology (1987)","source_url":"https://www.mainehealth.org/providers/scot-c-remick-md","status":"verified","collected_at":"2026-10-26"},{"value":"Board Certified, Internal Medicine (1985)","source_url":"https://www.mainehealth.org/providers/scot-c-remick-md","status":"verified","collected_at":"2026-10-26"},{"value":"MD, New York Medical College (1982)","source_url":"https://www.mainehealth.org/providers/scot-c-remick-md","status":"verified","collected_at":"2026-10-26"},{"value":"Fellow, American College of Physicians (FACP)","source_url":"https://www.tuftsctsi.org/people/scot-remick/","status":"verified","collected_at":"2026-10-26"}]},"roles":{"total":1,"shown":1,"rows":[{"value":"Editor-in-Chief, Journal of Maine Medical Center","source_url":"https://knowledgeconnection.mainehealth.org/jmmc/editorialboard.html","status":"verified","collected_at":"2026-10-26"}]},"awards":{"total":1,"shown":1,"rows":[{"value":"Chancellor's Award for Service, West Virginia University (2013)","source_url":"https://hsc.wvu.edu/hub/morgantown-campus/chancellors-awards/previous-award-winners/","status":"verified","collected_at":"2026-10-26"}]},"secondary_affiliations":{"total":3,"shown":3,"rows":[{"value":"Director of Oncology Research & Education, MaineHealth Institute for Research","source_url":"https://knowledgeconnection.mainehealth.org/jmmc/editorialboard.html","status":"verified","collected_at":"2026-10-26"},{"value":"Professor of Medicine, Tufts University School of Medicine","source_url":"https://www.tuftsctsi.org/people/scot-remick/","status":"verified","collected_at":"2026-10-26"},{"value":"Faculty affiliate, Tufts Clinical and Translational Science Institute (Tufts CTSI)","source_url":"https://www.tuftsctsi.org/people/scot-remick/","status":"verified","collected_at":"2026-10-26"}]},"media":{"total":1,"shown":1,"rows":[{"value":"TV news interview on WCSH-6/WLBZ-2 as Chief of Oncology discussing cancer awareness/stigma in immigrant communities (breast cancer among Black women)","source_url":"https://www.facebook.com/MaineMedicalCenter/posts/our-chief-of-oncology-dr-scot-remick-appeared-on-wcsh-6-and-wlbz-2-last-night-to/10155407192479383/","status":"provisional","collected_at":"2026-10-26"}]}},"similar":[{"name":"Seth Steinberg","slug":"seth-steinberg","institution":"National Cancer Institute (NCI)","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/seth-steinberg","json_url":"https://www.findmykol.com/kol/seth-steinberg/profile.json"},{"name":"Gilles Salles","slug":"gilles-salles","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/gilles-salles","json_url":"https://www.findmykol.com/kol/gilles-salles/profile.json"},{"name":"Thomas Witzig","slug":"thomas-witzig","institution":"Mayo Clinic","specialty":"Hematology","url":"https://www.findmykol.com/kol/thomas-witzig","json_url":"https://www.findmykol.com/kol/thomas-witzig/profile.json"},{"name":"Wyndham Wilson","slug":"wyndham-wilson","institution":"National Cancer Institute (NCI)","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/wyndham-wilson","json_url":"https://www.findmykol.com/kol/wyndham-wilson/profile.json"}],"coverage":{"note":"An identity-adjudicated profile: every section above was checked. Where a section states a count of zero, the public record was searched and nothing was found."},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":17,"funding":101,"congress":26,"network":37}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts","collected_at":"2026-10-26"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies","collected_at":"2026-10-26"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 to 2024","collected_at":"2026-10-26"},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year","collected_at":"2026-10-26"},"congress":{"name":"OpenAlex","url":"https://openalex.org","provides":"DOI-verified congress abstracts across AACR, ASCO, ASH, ASTRO, ESMO","disclaimer":"Congress abstracts are published as DOI-bearing journal supplements and attributed via the same ORCID-disambiguated authorship as publications.","collected_at":"2026-10-26"},"publications":{"name":"PubMed (NLM)","url":"https://pubmed.ncbi.nlm.nih.gov","provides":"Peer-reviewed publications, linked to the PubMed record","collected_at":"2026-10-26"}},"methodology_url":"https://www.findmykol.com/about#methodology"}